MIRA Pharmaceuticals, Inc.
MIRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17,606 | $19,494 | $94,664 | $94,664 |
| - Cash | $2,833 | $4,603 | $351 | $2,810 |
| + Debt | $0 | $5 | $491 | $293 |
| Enterprise Value | $14,773 | $14,897 | $94,804 | $92,148 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,018 | -$8,526 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$7,853 | -$11,982 | -$7,058 | -$2,177 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.51 | -0.65 | -0.48 | -0.15 |
| % Growth | 21.5% | -35.4% | -220% | – |
| Operating Cash Flow | -$5,561 | -$4,532 | -$5,605 | -$1,376 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$5,561 | -$4,532 | -$5,605 | -$1,376 |